Beximco Pharmaceuticals Limited (AIM:BXP)
London flag London · Delayed Price · Currency is GBP · Price in GBX
47.50
-0.39 (-0.82%)
Aug 15, 2025, 4:35 PM GMT+1

Beximco Pharmaceuticals Market Cap

Beximco Pharmaceuticals has a market cap or net worth of 312.69 million as of August 15, 2025. Its market cap has decreased by -14.98% in one year.

Market Cap
312.69M
Enterprise Value
356.99M
Revenue
309.11M
Ranking
n/a
PE Ratio
7.38
Stock Price
47.50

Market Cap Chart

Since January 3, 2000, Beximco Pharmaceuticals's market cap has increased from 22.96M to 312.69M, an increase of 1,261.80%. That is a compound annual growth rate of 10.73%.

History

DateMarket Cap% Change
Aug 14, 2025312.69M28.99%
Dec 30, 2024242.42M-48.09%
Dec 28, 2023466.99M-11.21%
Dec 29, 2022525.95M-29.56%
Dec 30, 2021746.62M1.29%
Dec 30, 2020737.12M192.11%
Dec 30, 2019 Pro Pro
Dec 27, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 179.76B
GSK plc 57.45B
Haleon 31.97B
Smith & Nephew 11.74B
ConvaTec Group 4.66B
Hikma Pharmaceuticals 3.97B
HUTCHMED (China) 2.09B
Oxford Nanopore Technologies 2.02B
Market Cap Rankings